REMEDY : BNSSG referral pathways & Joint Formulary


Home > Adults > Neurology >

Neuromuscular

Checked: 23-01-2023 by Vicky Ryan Next Review: 23-01-2025

Specialist Neuromuscular Services in BNSSG provided by South West Neuromuscular Operational Delivery Network

The South West Neuromuscular Operational Delivery Network (SWNODN) provides a specialist service for patients with neuromuscular conditions. Patients will be seen by members of the Multidisciplinary team and once seen, if appropriate, patients can opt to be registered for ongoing support.

The conditions covered include:

  • muscular dystrophies
  • neuropathies
  • myopathies
  • myasthenia
  • myotonic dystrophies

They do not see patients with:

  • MS (see separate referral guidelines)
  • Tremors
  • Movement Disorders
  • Seizures
  • Stroke
  • General Neurology conditions including Cerebral Palsy

Contact details

Services

ADULTS (18yrs +) - Specialist Neuromuscular Clinics - NBT

Dr Andria Merrison or Dr Clare Wood-Allum Consultant Neurologist, hold specialist neuromuscular clinics at Southmead Hospital. Each clinic gives patients access to a specialist neuromuscular physiotherapist, a neuromuscular advisor and a psychologist

Referrals to NBT must be sent under the Neuromuscular service via e-RS.

CHILDREN (0-17yrs) - Specialist Neuromuscular Clinics - BRCH

Dr Anirban Majumdar or Dr Archana Murugan Consultant Paediatric Neurologists hold specialist neuromuscular clinics at Bristol Royal Children’s Hospital. Referrals should be submitted via eRS. Please see website for further information: Paediatric Neurology Page Bristol Royal Hospital for Children.

Neurophysiotherapy

Please see the specific Neurophysiotherapy page.

Resources

South West Neuromuscular Operational Delivery Network

Muscular Dystrophy UK

Arts on Referral for Neuromuscular Condition - NBT



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.